325 related articles for article (PubMed ID: 28433101)
1. Wilson disease - currently used anticopper therapy.
Członkowska A; Litwin T
Handb Clin Neurol; 2017; 142():181-191. PubMed ID: 28433101
[TBL] [Abstract][Full Text] [Related]
2. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
3. Current Drug Managements of Wilson's Disease: From West to East.
Li WJ; Chen C; You ZF; Yang RM; Wang XP
Curr Neuropharmacol; 2016; 14(4):322-5. PubMed ID: 26639459
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
Appenzeller-Herzog C; Mathes T; Heeres MLS; Weiss KH; Houwen RHJ; Ewald H
Liver Int; 2019 Nov; 39(11):2136-2152. PubMed ID: 31206982
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of Wilson's disease.
Subramanian I; Vanek ZF; Bronstein JM
Curr Neurol Neurosci Rep; 2002 Jul; 2(4):317-23. PubMed ID: 12044251
[TBL] [Abstract][Full Text] [Related]
6. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
Purchase R
Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435
[TBL] [Abstract][Full Text] [Related]
7. Wilson disease.
El-Youssef M
Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
Brewer GJ; Askari F; Dick RB; Sitterly J; Fink JK; Carlson M; Kluin KJ; Lorincz MT
Transl Res; 2009 Aug; 154(2):70-7. PubMed ID: 19595438
[TBL] [Abstract][Full Text] [Related]
9. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
10. Recognition, diagnosis, and management of Wilson's disease.
Brewer GJ
Proc Soc Exp Biol Med; 2000 Jan; 223(1):39-46. PubMed ID: 10632959
[TBL] [Abstract][Full Text] [Related]
11. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment.
Pfeiffenberger J; Lohse CM; Gotthardt D; Rupp C; Weiler M; Teufel U; Weiss KH; Gauss A
J Inherit Metab Dis; 2019 Mar; 42(2):371-380. PubMed ID: 30746719
[TBL] [Abstract][Full Text] [Related]
12. Clinical considerations for an effective medical therapy in Wilson's disease.
Weiss KH; Stremmel W
Ann N Y Acad Sci; 2014 May; 1315():81-5. PubMed ID: 24754532
[TBL] [Abstract][Full Text] [Related]
13. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations.
Leung M; Wu Lanzafame J; Medici V
J Investig Med High Impact Case Rep; 2020; 8():2324709619896876. PubMed ID: 31920114
[No Abstract] [Full Text] [Related]
14. [Wilson disease in 2003].
Szalay F
Orv Hetil; 2003 Dec; 144(50):2451-8. PubMed ID: 15067983
[TBL] [Abstract][Full Text] [Related]
15. Wilson's disease: clinical, genetic and pharmacological findings.
Leggio L; Addolorato G; Abenavoli L; Gasbarrini G
Int J Immunopathol Pharmacol; 2005; 18(1):7-14. PubMed ID: 15698506
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
Schilsky ML
Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
[TBL] [Abstract][Full Text] [Related]
18. [Wilsons disease].
Mareček Z; Brůha R
Vnitr Lek; 2013 Jul; 59(7):578-83. PubMed ID: 23909262
[TBL] [Abstract][Full Text] [Related]
19. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
Brewer GJ
CNS Drugs; 2005; 19(3):185-92. PubMed ID: 15740174
[TBL] [Abstract][Full Text] [Related]
20. Wilson disease.
Członkowska A; Litwin T; Dusek P; Ferenci P; Lutsenko S; Medici V; Rybakowski JK; Weiss KH; Schilsky ML
Nat Rev Dis Primers; 2018 Sep; 4(1):21. PubMed ID: 30190489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
